Aichi, Japan

Haruo Takahashi


Average Co-Inventor Count = 6.3

ph-index = 5

Forward Citations = 61(Granted Patents)


Location History:

  • Aichi, JP (1991 - 1995)
  • Nagoya, JP (1991 - 1995)

Company Filing History:


Years Active: 1991-1995

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Haruo Takahashi: Innovator in Motilin Research

Introduction

Haruo Takahashi is a prominent inventor based in Aichi, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of motilin-like polypeptides. With a total of 9 patents to his name, Takahashi's work has advanced our understanding of gastrointestinal motility.

Latest Patents

Takahashi's latest patents include innovative processes for the preparation of motilin-like polypeptides. One notable patent details a recombinant DNA method for producing these polypeptides, along with a plasmid that incorporates the recombinant DNA. Another significant patent focuses on the use of orally absorbable motilin preparations designed to enhance gastrointestinal motility. This preparation contains a motilin-like active substance, primarily L-leucine-13-motilin-homoserine, combined with a surface-active agent such as bile salt, saponin, or polyethylene glycol higher-alcohol ether for nasal administration.

Career Highlights

Haruo Takahashi is affiliated with Sanwa Kagaku Kenkyusho Co., Ltd., where he continues to push the boundaries of research in his field. His work has not only contributed to scientific knowledge but also has practical applications in medicine and healthcare.

Collaborations

Throughout his career, Takahashi has collaborated with notable colleagues, including Kiichi Sawai and Masayasu Kurono. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Haruo Takahashi's contributions to the field of biotechnology, particularly in motilin research, highlight his role as a leading inventor. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…